WST
WEST PHARMACEUTICAL SERVICES, INC.
Surgical & Medical Instruments & Apparatus- 売上
- $3.1bn
- 時価総額
- $24.6bn
株価 $339.59 · 100株 3万円
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $2.9bn | $2.9bn | $3.1bn |
| 成長率 | — | ▲1.9% | 6.3% |
| 総利益 | $1.1bn | $999m | $1.1bn |
| 総利益率 | 38.3% | 34.5% | 35.9% |
| 販管費 | $353m | $339m | $394m |
| 販管費率 | 12.0% | 11.7% | 12.8% |
| 営利 | $676m | $570m | $585m |
| 営利率 | 22.9% | 19.7% | 19.0% |
| 純利益 | $593m | $493m | $494m |
| PBR | 8.5 | 9.2 | 7.7 |
| PSR | 8.3 | 8.5 | 8.0 |
| PGPR | 21.7 | 24.6 | 22.2 |
| PER | 41 | 50 | 50 |
| ﾈｯﾄｷｬｯｼｭ | $647m | $279m | $583m |
| EV/EBITDA | 29.4 | 33.5 | 31.7 |
| Rule of 40 | — | 18% | 25% |
| セールス効率 | — | — | 192% |
※Rule of 40は売上成長率＋営業利益率、セールス効率は売上総利益増加÷販管費増加（販管費増のときのみ）